Follow the Neuro$cience

“Neurotechnology Industry Reports Revenues of $143.1 Billion in 2009”

“Specific findings from the Neurotechnology Industry 2010 Report show that in 2009:

– Venture capital investment in neurotechnology was up 9.5% to $1.58 billion
– More than 250 venture investors participated in neurotech financings in 2009
– Global neurotech industry revenues shrank 1.2% to $143.1 billion
– Neuropharmaceuticals recorded revenues of $121 billion with -0.7% annual growth
– Neurodevices recorded revenues of $7.1 billion with 15% annual growth
– Neurodiagnostics recorded revenues of $15 billion with -11% annual growth

– Brain-related illness is the largest unmet medical market: 2 billion people worldwide”
Neuroinsights:
http://www.neuroinsights.com/neurotech2010release.html

neuropsychopharmacology?
“An implicit premise in neuropsychopharmacology with regard to the psychological aspects is that all states of mind, including both normal and drug-induced altered states, and diseases involving mental or cognitive dysfunction, have a neuro-chemical basis at the fundamental level, and certain circuit pathways in the central nervous system at a higher level.”
https://en.wikipedia.org/wiki/Neuropsychopharmacology#Overview

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s